JONATHAN T. LORD, M.D. - Corporate Board Profile

BIOLASE, INC

Filing Date	Source Excerpt
2016-04-07	Dr. Lord was appointed to the Board of Directors in August 2014 and serves as Chairman of our Compensation Committee. ... Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. ... Dr. Lord brings to our Board wide-ranging business and operational experience as well as his expertise in business transactions.
2017-04-05	Dr. Lord was appointed to our Board in August 2014 and serves as Chairman of our Compensation Committee. ... Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. ... The following table sets forth all compensation earned or paid to our non-employee directors during the year ended December 31, 2016. ... Jonathan T. Lord, M.D. ... Total $182,180 ... The Compensation Committee currently consists of Mr. Clark and Dr. Lord. Dr. Lord serves as its Chairman. ... The Nominating and Corporate Governance Committee currently consists of Messrs. Clark and Talevich and Drs. Lord and Moll.
2017-05-19	Jonathan T. Lord, M.D. Director Dr. Lord is a director of the Company.
2018-04-05	Dr. Lord was appointed to our Board in August 2014 and was appointed Chairman of the Board in September 2017. Dr. Lord also serves as Chairman of the Compensation Committee. ... Dr. Lord brings to our Board wide-ranging business and operational experience, including expertise in business transactions. ... The Audit Committee currently consists of Messrs. Sato and Talevich and Drs. Lord and Lanman. ... The Compensation Committee currently consists of Messrs. Sato and Talevich and Drs. Lord and Lanman. Dr. Lord serves as its Chairman. ... The Nominating and Corporate Governance Committee currently consists of Messrs. Sato and Talevich and Drs. Lord and Lanman. Dr. Lord serves as its Chairman.
2018-08-24	Jonathan T. Lord Chairman of the Board
2019-04-10	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. ... Drs. Lanman and Lord and Messrs. Roper and Sato are members of the Audit Committee and Drs. Lanman, Lord and Wagner and Mr. Sato are members of the Compensation Committee and the Nominating and Corporate Governance Committee. ... Our Board currently consists of five non-management directors and our President and Chief Executive Officer, Mr. Norbe. Dr. Lord, one of our independent directors, is Chairman of the Board. ... The following table sets forth all compensation earned or paid to our non-employee directors during the year ended December 31, 2018. ... Jonathan T. Lord, M.D. ... $249,603.
2020-04-23	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. ... The following table sets forth all compensation earned or paid to our non-employee directors during the year ended December 31, 2019. Jonathan T. Lord, M.D. 249,603
2020-12-11	By Order of the Board of Directors, Jonathan T. Lord Chairman of the Board
2021-04-19	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists... Dr. Lord brings to our Board wide-ranging business and operational experience, including expertise in business transactions. Total compensation: 213,634.
2021-10-08	By Order of the Board of Directors, Jonathan T. Lord, Chairman of the Board, Date: October 8, 2021. Also listed as a Director in the beneficial ownership table.
2022-03-30	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. Dr. Lord previously served as a director of Stericycle, Inc., a publicly traded medical and pharmaceutical waste management company, and MAKO Surgical Corp., a publicly traded medical device company that was sold to Stryker Corp. in 2013. Dr. Lord also serves or has served as a director of a number of private companies. Dr. Lord received a Bachelor of Science degree in Chemistry and a Doctor of Medicine degree from the University of Miami. Dr. Lord has also earned certificates in Governance and Audit from Harvard Business School. Mr. Lord brings to our Board wide-ranging business and operational experience, including expertise in business transactions.
2023-03-29	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. From March 2012 to January 2013, Dr. Lord was the Chief Operating Officer of the University of Miami Leonard M. Miller School of Medicine and the Uhealth- University of Miami Health System, a healthcare network in south Florida. Dr. Lord is also the former Chief Innovation Officer and Senior Vice President of Humana Inc. Dr. Lord previously served as a director of Stericycle, Inc., a publicly traded medical and pharmaceutical waste management company, and MAKO Surgical Corp., a publicly traded medical device company that was sold to Stryker Corp. in 2013. Dr. Lord also serves or has served as a director of a number of private companies. Dr. Lord received a Bachelor of Science degree in Chemistry and a Doctor of Medicine degree from the University of Miami. Dr. Lord has also earned certificates in Governance and Audit from Harvard Business School. Mr. Lord brings to our Board wide-ranging business and operational experience, including expertise in business transactions. The Audit Committee currently consists of Drs. Lord, O’Loughlin, Yale, and Mr. Roper. Mr. Roper serves as its Chairperson. The Compensation Committee currently consists of Drs. Lord, Summerhays, and Somerman. Dr. Lord serves as its Chairperson. The Nominating and Corporate Governance Committee currently consists of Drs. Lord, O’Loughlin, Somerman, Summerhays, Yale, and Mr. Roper. Dr. Lord serves as its Chairperson. The following table sets forth all compensation earned or paid to our non-employee directors who served all or a portion of the year ended December 31, 2022. Mr. Beaver did not received additional compensation for his service on our Board during 2022. Please see the “2022 Summary Compensation Table” for the compensation received by Mr. Beaver during 2022.
2023-06-21	Jonathan T. Lord, M.D. Chairman of the Board
2024-03-22	Dr. Lord is a board-certified forensic pathologist and Fellow of the College of American Pathologists. From March 2012 to January 2013, Dr. Lord was the Chief Operating Officer of the University of Miami Leonard M. Miller School of Medicine and the Uhealth- University of Miami Health System, a healthcare network in south Florida. From August 2011 to March 2012, Dr. Lord served as the Chief Innovation Officer at the University of Miami, Florida. From April 2009 to January 2010, Dr. Lord served as President and Chief Executive Officer of Navigenics, Inc., a privately held healthcare company. Prior to this role, he served as a senior executive in a variety of healthcare organizations including the Anne Arundel Medical Center and SunHealth and served as the Chief Operating Officer of the American Hospital Association. Dr. Lord is also the former Chief Innovation Officer and Senior Vice President of Humana Inc. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy Medical Department. From 2008 to 2017, Dr. Lord served on the board of directors of DexCom, Inc., a medical. device company focused on the design, development and commercialization of continuous glucose monitoring systems, and from 2010 to 2017, he served as its Chairman. Dr. Lord previously served as a director of Stericycle, Inc., a publicly traded medical and pharmaceutical waste management company, and MAKO Surgical Corp., a publicly traded medical device company that was sold to Stryker Corp. in 2013. Dr. Lord also serves or has served as a director of a number of private companies. Dr. Lord received a Bachelor of Science degree in Chemistry and a Doctor of Medicine degree from the University of Miami. Dr. Lord has also earned certificates in Governance and Audit from Harvard Business School. Dr. Lord brings to our Board wide-ranging business and operational experience, including expertise in business transactions. The Audit Committee currently consists of Drs. Lord, O’Loughlin, and Yale. Dr. Lord serves as its Chairperson. Our Board has determined that Dr. Lord qualifies as an “audit committee financial expert” under the SEC rules and meets the financial sophistication requirements of the NASDAQ Rules. Each member of the Audit Committee is independent as defined in the NASDAQ Rules, including the enhanced independence standards under the federal securities laws applicable to Audit Committee members. The Compensation Committee currently consists of Drs. Lord, O'Loughlin and Somerman. Dr. O'Loughlin serves as its Chairperson. Each of the current members of the Compensation Committee is independent as defined in the NASDAQ Rules, considering the additional standards for Compensation Committee members set forth therein, and qualifies as a “non-employee” director under SEC rules and regulations. The Nominating and Corporate Governance Committee currently consists of Drs. Lord, O’Loughlin, Somerman, and Yale. Dr. Lord serves as its Chairperson.